Utah's Amedica eyes $35 million IPO

Devicemaker Amedica is planning to go public with its sights on a $35 million IPO, offering 3.2 million shares at around $10 to $12 a piece. The Salt Lake City-based spinal implant specialist would operate under the Nasdaq symbol "AMDA." Item

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.